Company / Net Income
BIOCRYST PHARMACEUTICALS INC Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$263.9M
FY2025
5-year range
-$247.1M / $263.9M
FY2021-FY2025
Trend
+396.9%
vs FY2024
Sector context
#31 of 216
Health Care
What the data says
Net Income changed +397% YoY in FY2025, a notable deviation from the 9-year average annual change of +31%.
Based on SEC 10-K filings.
$264M in FY2025. Top quartile in the Health Care sector.
Improved from -$227M to $264M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 216This company $263.9M Sector average $454.1M
▼
-41.9% below sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's net income has grown for 3 consecutive years.
- In FY2025, net income increased 396.9% year-over-year.
- Ranks #31 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $263.9M | +396.9% |
| FY2024 | -$88.9M | +60.8% |
| FY2023 | -$226.5M | +8.3% |
| FY2022 | -$247.1M | -34.3% |
| FY2021 | -$184.1M | -0.7% |
| FY2020 | -$182.8M | -67.9% |
| FY2019 | -$108.9M | -7.6% |
| FY2018 | -$101.3M | -53.9% |
| FY2017 | -$65.8M | -19.3% |
| FY2016 | -$55.1M | -28.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026